By Jennifer Rigby and Emma Farge LONDON (Reuters) – Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make to fight future pandemics, under new rules being drawn up by the World Health Organization and reviewed by Reuters. A draft version of the WHO’s pandemic accord, which it hopes will be adopted by the U.N. health agency’s 194 member countries, calls for it to be compulsory for companies to reveal the terms of any public procurement contracts. [L1N32D1U4] It says that public funding for the development of vaccines and treatments should be more …